8 active not recruiting. 8 Phase 1, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 8 | Active not recruiting 8 |
| Phase 2 | 3 | Active not recruiting 3 |
Follow Behavioral Symptoms: new trials by email Literature Review of Behavioral Symptoms trials Research Report on Behavioral Symptoms
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Autonomous Digital CBT Intervention for Opioid Use Disorder in Individuals With Co-Occurring Internalizing Disorders NEAT-O program - Opioid Use Disorder, Anxiety | Phase 1 | Active not recruiting | University of Minnesota | 17 | 2025-08-21 | 2026-02-12 |
| Integrating Ketamine Effects on Neuronal Molecular Signatures and the Brain Functional and Structural Connectome ketamin - Depression, Suicide | Phase 1 | Active not recruiting | Massachusetts General Hospital | 120 | 2025-01-01 | 2026-05-22 |
| Neurobiological Effects of Psilocybin in Treatment Resistant Bipolar Depression Psilocybin, Functional MRI - Bipolar Depression | Phase 1 | Active not recruiting | University Health Network, Toronto | 30 | 2024-10-09 | 2026-08-10 |
| PSilocybin for psYCHological and Existential Distress in PALliative Care (PSYCHED-PAL) Psilocybin - Depression, Anxiety, Distress, Emotional | Phase 1 / Phase 2 | Active not recruiting | Ottawa Hospital Research Institute | 20 | 2024-01-08 | 2026-07-10 |
| ELE-101 Safety & Tolerability Study in Healthy Participants and Patients With Depression ELE-101, ELE-101 Placebo - Healthy Volunteers, Major Depressive Disorder | Phase 1 / Phase 2 | Active not recruiting | Eleusis Therapeutics | 84 | 2022-10-27 | 2025-02-19 |
| Fixed Order, Open-Label, Dose-Escalation Study of DMT in Humans 0.1 mg/kg Dimethyltryptamine (DMT), 0.3 mg/kg Dimethyltryptamine (DMT) - Major Depressive Disorder, Depression | Phase 1 | Active not recruiting | Yale University | 30 | 2021-03-17 | 2025-08-03 |
| Smoking Cessation for Depressed Smokers Smoking Cessation Treatment, Nicotine Replacement Therapy, CBASP - Smoking, Depression | Phase 1 / Phase 2 | Active not recruiting | M.D. Anderson Cancer Center | 91 | 2007-06-28 | 2026-06-15 |
| Depression Treatment and Screening in Ovarian Cancer Patients Telephone Counseling, Usual Care - Ovarian Cancer, Peritoneal Cancer | Phase 1 | Active not recruiting | M.D. Anderson Cancer Center | 409 | 2002-12-20 | 2026-09-18 |
Depression (8) · Depressive Disorder, Major (3) · Anxiety Disorders (2) · Bipolar Disorder (1) · Depressive Disorder, Treatment-Resistant (1) · Fallopian Tube Neoplasms (1) · Opioid-Related Disorders (1) · Ovarian Neoplasms (1) · Smoking (1) · Suicide (1)
Behavior (8) · Mental Disorders (6) · Depressive Disorder (4) · Mood Disorders (4) · Adnexal Diseases (1) · Bipolar and Related Disorders (1) · Chemically-Induced Disorders (1) · Endocrine Gland Neoplasms (1) · Endocrine System Diseases (1) · Fallopian Tube Diseases (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Genital Diseases (1) · Genital Diseases, Female (1)
Psilocybin (2) · Magnetic Resonance Imaging (1) · N,N-Dimethyltryptamine (1) · Nicotine Replacement Therapy (1) · Surveys and Questionnaires (1)
M.D. Anderson Cancer Center (2) · Eleusis Therapeutics (1) · Massachusetts General Hospital (1) · Ottawa Hospital Research Institute (1) · University Health Network, Toronto (1) · University of Minnesota (1) · Yale University (1)
United States (5) · Canada (2) · United Kingdom (1)
Eileen H. Shinn, PhD (1) · James Downar, MDCM, MSc (1) · Jan Blalock, PhD (1) · Joshua Rosenblat, MD, MSc (1) · Neel Bhatt (1)
K07CA093512 (1), R01MH076776 (1), R01MH087692 (1), UG3DA059414 (1)